Pioneer Group Partners with Thermo Fisher to Empower Biotech Startups in Healthcare and Sustainability

Pioneer Group has  announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commerci...

January 16, 2025 | Thursday | News
Acadia Pharmaceuticals Submits Marketing Authorization Application for Trofinetide in the EU for Rett Syndrome Treatment

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced that the company has submitted a Marketing Authorization Application (MAA) to the European M...

January 15, 2025 | Wednesday | News
Grifols Receives $21 Million Grant from The Michael J. Fox Foundation to Advance Early Detection of Parkinson's Disease

Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, announced it has received a...

January 15, 2025 | Wednesday | News
AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan (Dato-DXd) Receives FDA Priority Review for EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority Rev...

January 14, 2025 | Tuesday | News
HMNC Brain Health Reaches Key Milestone with Successful Patient Randomization in Phase 2b OLIVE Trial for Major Depressive Disorder

HMNC Brain Health (“HMNC”), a clinical-stage precision psychiatry biopharma company pioneering personalized treatments powered by predictive co...

January 14, 2025 | Tuesday | News
Menarini and Stemline Secure Global Rights to Innovative Oncology Small Molecule in Partnership with Insilico Medicine

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-own...

January 13, 2025 | Monday | News
Gilead Sciences and LEO Pharma Form Strategic Partnership to Advance STAT6 Oral Therapies for Inflammatory Diseases

-Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma  announced a strategic partnership to accelerate the development and commercializatio...

January 13, 2025 | Monday | News
QIAcuity Digital PCR Expands Capacity to 12 Targets Simultaneously with New Software Update and High Multiplex PCR Kit

  QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold inc...

January 13, 2025 | Monday | News
Samsung Bioepis and Teva Forge Strategic Partnership for U.S. Launch of EPYSQLI® Biosimilar

Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) announced that the companies have entered into a license, developm...

January 13, 2025 | Monday | News
Grifols Submits Biologics License Application for New Fibrinogen Treatment to FDA

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has submitted a B...

January 10, 2025 | Friday | News
etherna Immunotherapies and Dropshot Therapeutics Join Forces to Accelerate RNA-Based Therapeutics Development

etherna immunotherapies NV (“etherna”), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announc...

January 10, 2025 | Friday | News
Positive SIRONA Study Results Highlight Sirolimus-Coated Balloons as Effective Alternative to Paclitaxel for PAD Treatment

Concept Medical Inc., a global leader in innovative drug delivery technologies, is proud to report positive results from the SIRONA (Head-to-Head...

January 08, 2025 | Wednesday | News
Briggs Morrison, M.D., Joins CRISPR Therapeutics to Propel Innovation in Gene Editing

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced it ...

January 08, 2025 | Wednesday | News
GSK Secures FDA Breakthrough Therapy Designation for GSK5764227 in Relapsed Osteosarcoma

GSK plc (LSE/NYSE: GSK) announced  that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK&rsq...

January 08, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close